Gastro-Oesophageal Reflux Disease Clinical Trial
Official title:
A Study to Assess the Effectiveness of Esomeprazole 40 mg Once Daily in Subjects With Continuing Gastroesophageal Reflux Disease (GORD) Symptoms Following Treatment Wit a Previous Full Dose Proton Pump Inhibitor (PPI)
The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing symptoms will benefit from a change in treatment.
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03793556 -
Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
|
N/A | |
| Completed |
NCT01507298 -
Physical Activity and Gastrointestinal Investigations
|
||
| Recruiting |
NCT06317675 -
Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease
|
Phase 2 |